glp-1 increased heart rate Cardiovascular Protection with a Long-Acting Receptor Agonist Liraglutide: An Experimental Update Are you noticing your heart

Woodward, Effects of dulaglutide and insulin glargine on estimated glomerular filtration rate in a real-world setting

Importantly, consider the broader clinical picture

Leptin, a key regulator of satiety and appetite, is decreased in active IBD, probably due to exhaustion after transient overproduction related to TNF- hyperactivity

Notably, genome-wide association study (GWAS) analyses for body mass index (BMI) have linked glutamatergic signalling and NMDA receptor-related neuroplasticity to regulation of body weight and obesity 1,5

The optional MadeMed Club membership costs $149 per year and reduces monthly costs by $10 to $20 depending on the program

Summary: Retatrutide is an investigational triple hormone receptor agonist peptide (GLP-1, GIP, and glucagon) developed by Eli Lilly for obesity treatment, currently in Phase 3 trials and not yet approved by the MHRA or EMA